Startup Funding Tracker
Home›People›Tim Kutzkey
TK

Tim Kutzkey

10% owner at Eikon Therapeutics. Also a director at NGM Bio, Neurona Therapeutics and Carmot Therapeutics.

ExecutiveDirectorPublic companyRoles at 3 startups
Updated Nov 9, 2026·Latest SEC filing Sep 8, 2026·Suggest an edit

About Tim Kutzkey

Tim Kutzkey is a 10% owner at Eikon Therapeutics.

Form D filings name Tim Kutzkey as a director at NGM Bio, Neurona Therapeutics and Carmot Therapeutics.

Tim Kutzkey reports to the SEC as a director or major shareholder of 10 public companies, including Surrozen (SRZN), Tenaya Therapeutics (TNYA) and RAPT Therapeutics (RAPT).

Tim Kutzkey first appears on SEC filings in 2010.

Experience

This experience comes from SEC filings. The years are when the filings name Tim Kutzkey in the role, so the role may have started earlier or lasted longer.

Eikon Therapeutics, Inc.
10% owner
2026 · Public company (EIKN)
Surrozen, Inc.
Director and 10% owner
2021 – 2026 · Public company (SRZN)
NGM Bio Holdings, Inc.
Director
2026 · South San Francisco, CA
Develops medicines for people with serious diseases through its subsidiary.
Tenaya Therapeutics, Inc.
10% owner
2026 · Public company (TNYA)
Neurona Therapeutics, Inc.
Director
2014 – 2025 · South San Francisco, CA
RAPT Therapeutics, Inc.
10% owner
2019 – 2024 · Public company (RAPT)
NGM Biopharmaceuticals Inc.
10% owner
2019 – 2024 · Public company (NGM)
Carmot Therapeutics Inc.
Director
2010 – 2023 · Berkeley, CA
Nurix Therapeutics, Inc.
10% owner
2020 – 2021 · Public company (NRIX)
Constellation Pharmaceuticals Inc.
10% owner
2018 – 2021 · Public company (CNST)
Revolution Medicines, Inc.
10% owner
2020 · Public company (RVMD)
Immune Design Corp.
10% owner
2017 – 2019 · Public company (IMDZ)
Arcus Biosciences, Inc.
10% owner
2018 · Public company (RCUS)

Key Colleagues at Startups

The people Tim Kutzkey works with at each company, as listed on that company's latest Form D.

NGM Bio Holdings, Inc. · Form D/A, Mar 27, 2026
Diana Bockus
Diana Bockus
Chief Executive Officer and director
RP
PS
Neurona Therapeutics, Inc. · Form D, Apr 4, 2025
PS
BM
Brad Margus
Director
CN
Cory Nicholas
Executive officer, director and promoter
JS
James Stutz
Chief Financial Officer
RK
Ray Kelleher
Director
EW
LG
Leo Guthart
Director
Carmot Therapeutics Inc. · Form D, Jun 6, 2023
AD
PS
AT
TG
SD
HT
Heather Turner
Chief Executive Officer and director

Sources

  1. SECNGM Bio Holdings, Inc. Form D/A, filed Mar 27, 2026
  2. SECNeurona Therapeutics, Inc. Form D, filed Apr 4, 2025
  3. SECCarmot Therapeutics Inc. Form D, filed Jun 6, 2023
  4. SECForms 3, 4 and 5 filed by Tim Kutzkey (SEC filer 1614186)